Browse
Register
Log In
Variables
4291 variables.
Search variables
---------
Activity tracker (CHRIS follow-up) (md_x1_0139)
Administrative data (CHRIS baseline) (md_x0_0022)
Administrative data (CHRIS follow-up) (md_x1_0022)
Affinity-based plasma proteomics (CHRIS baseline) (md_x0_0103)
Affinity-based plasma proteomics (Upcoming, CHRIS baseline) (md_up_0011)
Alcohol (CHRIS baseline) (md_x0_0037)
Alcohol (CHRIS follow-up) (md_x1_0037)
Anthropometry (CHRIS baseline) (md_x0_0012)
Anthropometry (CHRIS follow-up) (md_x1_0012)
Anthropometry form (CHRIS follow-up) (md_x1_0135)
Anxiety (CHRIS baseline) (md_x0_0098)
Anxiety (CHRIS follow-up) (md_x1_0098)
Arthritis (CHRIS follow-up) (md_x1_0130)
Autonomic system (CHRIS baseline) (md_x0_0089)
Autonomic system (CHRIS follow-up) (md_x1_0089)
Baseline information (CHRIS COVID-19) (md_cc_0002)
Biochemical traits (CHRIS COVID-19) (md_cc_0003)
Biochemical traits (CHRIS baseline) (md_x0_0002)
Biochemical traits (CHRIS follow-up) (md_x1_0002)
Birth (CHRIS baseline) (md_x0_0038)
Blood (CHRIS COVID-19) (ms_cc_0002)
Blood (CHRIS NAFLD) (ms_na_0002)
Blood (CHRIS PAREGEN1) (ms_p1_0002)
Blood (CHRIS PAREGEN2) (ms_p2_0002)
Blood (CHRIS baseline) (ms_x0_0002)
Blood (CHRIS follow-up) (ms_x1_0002)
Blood collection form (CHRIS baseline) (md_x0_0007)
Blood collection form (CHRIS follow-up) (md_x1_0007)
Blood drawing pain rating (CHRIS follow-up) (md_x1_0134)
Blood measurements (CHRIS baseline) (md_x0_0009)
Blood measurements (CHRIS follow-up) (md_x1_0009)
Blood pressure (CHRIS baseline) (md_x0_0013)
Blood pressure (CHRIS follow-up) (md_x1_0013)
Blood values (CHRIS baseline) (md_x0_0039)
Blood values (CHRIS follow-up) (md_x1_0039)
CHRIS COVID-19 data (md_cc_0001)
CHRIS COVID-19 samples (ms_cc_0001)
CHRIS NAFLD data (md_na_0001)
CHRIS NAFLD samples (ms_na_0001)
CHRIS PAREGEN1 data (md_p1_0001)
CHRIS PAREGEN1 samples (ms_p1_0001)
CHRIS PAREGEN2 data (md_p2_0001)
CHRIS PAREGEN2 samples (ms_p2_0001)
CHRIS baseline data (md_x0_0001)
CHRIS baseline samples (ms_x0_0001)
CHRIS data (md_x_0001)
CHRIS follow-up data (md_x1_0001)
CHRIS follow-up data (Upcoming CHRIS follow-up) (md_up_0010)
CHRIS follow-up samples (ms_x1_0001)
CHRIS samples (ms_x_0001)
CHRIS sub-study data (md_xs_0001)
CHRIS sub-study samples (ms_xs_0001)
COVID-19 infection (CHRIS follow-up) (md_x1_0123)
COVID-19 vaccination (CHRIS follow-up) (md_x1_0117)
Cancer (CHRIS baseline) (md_x0_0040)
Cancer (CHRIS follow-up) (md_x1_0040)
Cardiac arrhythmias (CHRIS baseline) (md_x0_0041)
Cardiac arrhythmias (CHRIS follow-up) (md_x1_0041)
Cardiovascular diseases (CHRIS baseline) (md_x0_0042)
Cardiovascular diseases (CHRIS baseline) (md_x0_0107)
Cardiovascular traits (CHRIS baseline) (md_x0_0114)
Cardiovascular traits (CHRIS follow-up) (md_x1_0114)
Childhood trauma (CHRIS baseline) (md_x0_0081)
Chronic diseases (CHRIS baseline) (md_x0_0043)
Chronic diseases (CHRIS follow-up) (md_x1_0043)
Chronic pain (CHRIS baseline) (md_x0_0044)
Chronic pain (CHRIS follow-up) (md_x1_0124)
Chronotype (CHRIS baseline) (md_x0_0091)
Circulation (CHRIS baseline) (md_x0_0045)
Circulation (CHRIS follow-up) (md_x1_0045)
Clinical traits (CHRIS baseline) (md_x0_0011)
Clinical traits (CHRIS follow-up) (md_x1_0011)
Cognition (CHRIS baseline) (md_x0_0070)
Complement system (CHRIS baseline) (md_x0_0004)
Complement system, additional batch (Upcoming, CHRIS baseline) (md_up_0009)
Continuous blood pressure measurement (CHRIS baseline) (md_x0_0118)
Corticosteroids (Upcoming, CHRIS baseline) (md_up_0008)
Cumulative Illness Rating Scale (CHRIS baseline) (md_x0_0115)
Data-derived traits (CHRIS baseline) (md_x0_0106)
Data-derived traits (CHRIS follow-up) (md_x1_0106)
Day summary (md_x1_0140)
Demographic data (CHRIS baseline) (md_x0_0024)
Demographic data (CHRIS follow-up) (md_x1_0024)
Depression (CHRIS baseline) (md_x0_0090)
Depression (CHRIS follow-up) (md_x1_0090)
Depression and mania (CHRIS baseline) (md_x0_0085)
Derived traits (CHRIS baseline) (md_x0_0104)
Derived traits (CHRIS follow-up) (md_x1_0104)
Diabetes (CHRIS baseline) (md_x0_0046)
Diabetes (CHRIS follow-up) (md_x1_0046)
Drug intake (CHRIS baseline) (md_x0_0018)
Drug intake (CHRIS follow-up) (md_x1_0018)
Drugs complete dataset (CHRIS follow-up) (md_x1_0019)
Drugs summary (CHRIS baseline) (md_x0_0020)
Drugs summary (CHRIS follow-up) (md_x1_0020)
Dynamic consent survey (CHRIS baseline) (md_x0_0109)
ECG 10s (CHRIS baseline) (md_x0_0015)
ECG 10s (CHRIS follow-up) (md_x1_0015)
ECG 20m (CHRIS baseline) (md_x0_0016)
ECG representations based on 32 generative factors (Upcoming, CHRIS baseline) (md_up_0015)
Early repolarization pattern (CHRIS baseline) (md_x0_0116)
Exposure (CHRIS baseline) (md_x0_0047)
Feces (CHRIS NAFLD) (ms_na_0005)
Flavonoid intake (CHRIS baseline) (md_x0_0078)
Flavonoid intake (CHRIS follow-up) (md_x1_0078)
Food frequency questionnaire (CHRIS baseline) (md_x0_0077)
Food frequency questionnaire (CHRIS follow-up) (md_x1_0077)
General health (CHRIS follow-up) (md_x1_0128)
General information (CHRIS COVID-19) (md_cc_0004)
General information (CHRIS baseline) (md_x0_0021)
General information (CHRIS follow-up) (md_x1_0021)
Genomic variants (CHRIS baseline) (md_x0_0026)
Genomics (CHRIS baseline) (md_x0_0025)
Genotype array (CHRIS baseline) (md_x0_0028)
Gynecology (CHRIS baseline) (md_x0_0048)
Gynecology (CHRIS follow-up) (md_x1_0048)
Handedness (CHRIS follow-up) (md_x1_0136)
Heart failure (CHRIS baseline) (md_x0_0049)
Heart failure (CHRIS follow-up) (md_x1_0049)
Heart rate variability (CHRIS baseline) (md_x0_0113)
Heart rate variability, cardiologist curated (CHRIS baseline) (md_x0_0112)
Hypertension (CHRIS follow-up) (md_x1_0116)
Hypomania (CHRIS baseline) (md_x0_0082)
Illness rating (CHRIS follow-up) (md_x1_0129)
Infectious diseases (CHRIS follow-up) (md_x1_0122)
Informed consent (CHRIS follow-up) (md_x1_0110)
Informed consent (CHRIS baseline) (md_x0_0110)
Insomnia (CHRIS follow-up) (md_x1_0121)
Interpretation (CHRIS follow-up) (md_x1_0133)
Interview (CHRIS baseline) (md_x0_0036)
Interview (CHRIS follow-up) (md_x1_0036)
Iron metabolism (CHRIS baseline) (md_x0_0005)
Iron metabolism (Upcoming, CHRIS baseline) (md_up_0003)
Kidney diseases (CHRIS baseline) (md_x0_0050)
Kidney diseases (CHRIS follow-up) (md_x1_0050)
Lab routine measurements (CHRIS baseline) (md_x0_0008)
Lab routine measurements (CHRIS follow-up) (md_x1_0008)
Longitudinal information (CHRIS COVID-19) (md_cc_0005)
MICROS data (md_mi_0001)
MICROS samples (ms_mi_0001)
Major psychiatric diagnoses (CHRIS baseline) (md_x0_0084)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS COVID 19) (md_up_0014)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS baseline, CHRIS NAFLD) (md_up_0007)
Mass-spectrometry plasma proteomics: peptides (CHRIS NAFLD) (md_na_0101)
Mass-spectrometry plasma proteomics: peptides (CHRIS baseline) (md_x0_0101)
Mass-spectrometry plasma proteomics: proteins (CHRIS NAFLD) (md_na_0102)
Mass-spectrometry plasma proteomics: proteins (CHRIS baseline) (md_x0_0102)
Metabolomics (CHRIS NAFLD) (md_na_0063)
Metabolomics (CHRIS baseline) (md_x0_0063)
Metagenomes from saliva and feces (Upcoming, CHRIS NAFLD) (md_up_0016)
Migraine (CHRIS baseline) (md_x0_0051)
Mitochondrial DNA (Upcoming, CHRIS baseline) (md_up_0019)
Mitochondrial DNA copy number (CHRIS baseline) (md_x0_0006)
Movement disorder examination (CHRIS baseline) (md_x0_0111)
Myocardial infarction (CHRIS baseline) (md_x0_0052)
Myocardial infarction (CHRIS follow-up) (md_x1_0052)
NAFLD sub-study data (Upcoming CHRIS NAFLD) (md_up_0006)
NOT IN USE (md_x_0003)
NOT IN USE md_x0_0033 (md_x0_0033)
NOT IN USE md_x0_0034 (md_x0_0034)
NOT IN USE md_x0_0122 (md_x0_0122)
NOT IN USE md_x0_0123 (md_x0_0123)
NOT IN USE md_x0_0124 (md_x0_0124)
NOT IN USE md_x0_0125 (md_x0_0125)
NOT IN USE ms_x0_0005 (ms_x0_0005)
NOT IN USE ms_x0_0006 (ms_x0_0006)
NOT IN USE ms_x0_0007 (ms_x0_0007)
NOT IN USE ms_x0_0008 (ms_x0_0008)
NOT IN USE ms_x0_0009 (ms_x0_0009)
NOT IN USE ms_x0_0010 (ms_x0_0010)
NOT IN USE ms_x0_0011 (ms_x0_0011)
NOT IN USE test (test)
NOT IN USE upcoming_0001 (upcoming_0001)
NOT IN USE upcoming_0002 (upcoming_0002)
NOT IN USE upcoming_0003 (upcoming_0003)
NOT IN USE upcoming_0004 (upcoming_0004)
Neurological phenotypes (CHRIS baseline) (md_x0_0108)
Neurological phenotypes (CHRIS follow-up) (md_x1_0108)
Neurological tests (CHRIS baseline) (md_x0_0068)
Neurological tests (CHRIS follow-up) (md_x1_0068)
Neurology (CHRIS baseline) (md_x0_0053)
Neurology (CHRIS follow-up) (md_x1_0053)
Neuropsychiatry questionnaire (CHRIS baseline) (md_x0_0080)
Neutralizing Antibody (CHRIS COVID-19) (md_cc_0006)
Notes (CHRIS follow-up) (md_x1_0138)
Nutrient intake (CHRIS baseline) (md_x0_0079)
Nutrient intake (CHRIS follow-up) (md_x1_0079)
Nutrition (CHRIS baseline) (md_x0_0054)
Occupation (CHRIS baseline) (md_x0_0055)
Occupation (CHRIS follow-up) (md_x1_0055)
Olfaction (CHRIS follow-up) (md_x1_0118)
Olfactory test (CHRIS baseline) (md_x0_0071)
Olfactory test (CHRIS follow-up) (md_x1_0071)
Optimism and pessimism (CHRIS baseline) (md_x0_0083)
Oral health (CHRIS baseline) (md_x0_0099)
Other diseases (CHRIS baseline) (md_x0_0056)
PAREGEN sub-study data (Upcoming, CHRIS PAREGEN) (md_up_0017)
PAREGEN2 sub-study data (Upcoming, CHRIS PAREGEN2) (md_up_0018)
Pain Sensitivity (CHRIS follow-up) (md_x1_0092)
Pain pressure threshold (CHRIS baseline) (md_x0_0069)
Pain sensitivity (CHRIS baseline) (md_x0_0092)
Pain sensitivity assessement (CHRIS follow-up) (md_x1_0119)
Pain staging (CHRIS follow-up) (md_x1_0125)
Parkinson screening (CHRIS baseline) (md_x0_0057)
Participant satisfaction survey (CHRIS follow-up) (md_x1_0132)
Participation information (CHRIS baseline) (md_x0_0023)
Participation information (CHRIS follow-up) (md_x1_0023)
Pedigree (CHRIS baseline) (md_x0_0074)
Person (CHRIS baseline) (md_x0_0058)
Person (CHRIS follow-up) (md_x1_0058)
Physical activity (CHRIS baseline) (md_x0_0093)
Physical activity (CHRIS follow-up) (md_x1_0093)
Proteomics (CHRIS NAFLD) (md_na_0100)
Proteomics (CHRIS baseline) (md_x0_0100)
Public imputation panels (CHRIS baseline) (md_x0_0027)
REM sleep (CHRIS baseline) (md_x0_0095)
REM sleep (CHRIS follow-up) (md_x1_0095)
Raw recordings ECG 10s (CHRIS baseline) (md_x0_0119)
Raw recordings ECG 20m (CHRIS baseline) (md_x0_0120)
Raw recordings spiralography (CHRIS baseline) (md_x0_0121)
Renin-angiotensin-aldosteron system (Upcoming, CHRIS baseline) (md_up_0005)
Resting ECG (CHRIS baseline) (md_x0_0014)
Resting ECG (CHRIS follow-up) (md_x1_0014)
Restless Legs Syndrome (CHRIS baseline) (md_x0_0096)
SARS-CoV-2 antibody (CHRIS follow-up) (md_x1_0115)
Saliva (CHRIS NAFLD) (ms_na_0004)
Saliva (CHRIS baseline) (ms_x0_0004)
Saliva microbiome (Upcoming, CHRIS baseline) (md_up_0013)
Sample-derived traits (CHRIS baseline) (md_x0_0105)
Sample-derived traits (CHRIS follow-up) (md_x1_0105)
Self-Assessement (CHRIS baseline) (md_x0_0076)
Self-Assessement (CHRIS follow-up) (md_x1_0076)
Self-Assessement at home (CHRIS follow-up) (md_x1_0127)
Self-reported ancestry (CHRIS baseline) (md_x0_0075)
Sleep behavior (CHRIS follow-up) (md_x1_0120)
Sleep quality (CHRIS baseline) (md_x0_0094)
Smoking (CHRIS baseline) (md_x0_0059)
Smoking (CHRIS follow-up) (md_x1_0059)
Socio-economic panel (CHRIS follow-up) (md_x1_0126)
Socio-economic panel, at home (CHRIS follow-up) (md_x1_0131)
Spiralography (CHRIS baseline) (md_x0_0072)
Stress perception (CHRIS baseline) (md_x0_0086)
Stroke (CHRIS baseline) (md_x0_0060)
Stroke (CHRIS follow-up) (md_x1_0060)
Summary (md_x1_0141)
Surgeries (CHRIS follow-up) (md_x1_0137)
TOPMed-imputed genotypes (CHRIS baseline) - NOT IN USE (md_x0_0030)
Targeted serum metabolomics (CHRIS NAFLD) (md_na_0065)
Targeted serum metabolomics (CHRIS baseline) (md_x0_0065)
Targeted serum metabolomics, expanded set (CHRIS baseline) (md_x0_0064)
Targeted serum metabolomics, expanded set (Upcoming, CHRIS baseline) (md_up_0004)
Temperament (CHRIS baseline) (md_x0_0087)
Thyroid diseases (CHRIS baseline) (md_x0_0061)
Thyroid diseases (CHRIS follow-up) (md_x1_0061)
Touchscreen (CHRIS baseline) (md_x0_0088)
Touchscreen (CHRIS follow-up) (md_x1_0088)
Untargeted serum metabolomics (Upcoming, CHRIS baseline) (md_up_0012)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS NAFLD) (md_na_0066)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS baseline) (md_x0_0066)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS NAFLD) (md_na_0067)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS baseline) (md_x0_0067)
Upcoming datasets (md_up_0001)
Urine (CHRIS NAFLD) (ms_na_0003)
Urine (CHRIS baseline) (ms_x0_0003)
Urine (CHRIS follow-up) (ms_x1_0003)
Urine measurements (CHRIS baseline) (md_x0_0010)
Urine measurements (CHRIS follow-up) (md_x1_0010)
Vaccination (CHRIS baseline) (md_x0_0062)
Vaccination status (CHRIS COVID-19) (md_cc_0007)
Whole-exome sequencing (CHRIS baseline) (md_x0_0029)
Whole-exome sequencing imputation (CHRIS baseline) (md_x0_0031)
Whole-exome sequencing raw data (CHRIS baseline) (md_x0_0032)
Without expected release date (md_up_0002)
Module
---------
Label
Character
Integer
Categorical
Float
Date
Time
Datetime
Boolean
Type
Search
Clear
Module
Label
Name
Description
Type
ECG 10s (CHRIS baseline)
x0ec126g
S-Amplitude, V1
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead V1
Float
ECG 10s (CHRIS baseline)
x0ec126f
S-Amplitude, aVF
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec126e
S-Amplitude, aVL
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec126c
S-Amplitude, III
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead III
Float
ECG 10s (CHRIS baseline)
x0ec126b
S-Amplitude, II
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead II
Float
ECG 10s (CHRIS baseline)
x0ec126a
S-Amplitude, I
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead I
Float
ECG 10s (CHRIS baseline)
x0ec124b
Median of RR-Intervals
Median of RR-Intervals (computed over the customed beat series), expressed in milliseconds
Float
ECG 10s (CHRIS baseline)
x0ec124a
Mean of RR-Intervals
Mean of RR-Intervals (computed over the customed beat series), expressed in milliseconds
Float
ECG 10s (CHRIS baseline)
x0ec123k
R'-Amplitude, V5
Voltage amplitude of the peak of R wave in the first derivative of ECG, expressed in milliVolts, measured in lead V5
Float
ECG 10s (CHRIS baseline)
x0ec123j
R'-Amplitude, V4
Voltage amplitude of the peak of R wave in the first derivative of ECG, expressed in milliVolts, measured in lead V4
Float
ECG 10s (CHRIS baseline)
x0ec123i
R'-Amplitude, V3
Voltage amplitude of the peak of R wave in the first derivative of ECG, expressed in milliVolts, measured in lead V3
Float
ECG 10s (CHRIS baseline)
x0ec123g
R'-Amplitude, V1
Voltage amplitude of the peak of R wave in the first derivative of ECG, expressed in milliVolts, measured in lead V1
Float
ECG 10s (CHRIS baseline)
x0ec123f
R'-Amplitude, aVF
Voltage amplitude of the peak of R wave in the first derivative of ECG, expressed in milliVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec123e
R'-Amplitude, aVL
Voltage amplitude of the peak of R wave in the first derivative of ECG, expressed in milliVolts, measured in lead aVL
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt164
SM (OH) C22:1
Hydroxysphingomyeline C22:1
Float
ECG 10s (CHRIS baseline)
x0ec123d
R'-Amplitude, aVR
Voltage amplitude of the peak of R wave in the first derivative of ECG, expressed in milliVolts, measured in lead aVR
Float
ECG 10s (CHRIS baseline)
x0ec123c
R'-Amplitude, III
Voltage amplitude of the peak of R wave in the first derivative of ECG, expressed in milliVolts, measured in lead III
Float
ECG 10s (CHRIS baseline)
x0ec123b
R'-Amplitude, II
Voltage amplitude of the peak of R wave in the first derivative of ECG, expressed in milliVolts, measured in lead II
Float
ECG 10s (CHRIS baseline)
x0ec123a
R'-Amplitude, I
Voltage amplitude of the peak of R wave in the first derivative of ECG, expressed in milliVolts, measured in lead I
Float
ECG 10s (CHRIS baseline)
x0ec121l
R-Amplitude, V6
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec121k
R-Amplitude, V5
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead V5
Float
ECG 10s (CHRIS baseline)
x0ec121j
R-Amplitude, V4
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead V4
Float
ECG 10s (CHRIS baseline)
x0ec121h
R-Amplitude, V2
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead V2
Float
ECG 10s (CHRIS baseline)
x0ec121g
R-Amplitude, V1
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead V1
Float
ECG 10s (CHRIS baseline)
x0ec121f
R-Amplitude, aVF
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec121e
R-Amplitude, aVL
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec121d
R-Amplitude, aVR
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead aVR
Float
ECG 10s (CHRIS baseline)
x0ec121c
R-Amplitude, III
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead III
Float
ECG 10s (CHRIS baseline)
x0ec121b
R-Amplitude, II
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead II
Float
ECG 10s (CHRIS baseline)
x0ec121a
R-Amplitude, I
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead I
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt165
SM (OH) C22:2
Hydroxysphingomyeline C22:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt166
SM (OH) C24:1
Hydroxysphingomyeline C24:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt167
SM C16:0
Sphingomyeline C16:0
Float
ECG 10s (CHRIS baseline)
x0ec110l
Q-Amplitude, V6
Voltage amplitude of the peak of Q wave, expressed in milliVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec110k
Q-Amplitude, V5
Voltage amplitude of the peak of Q wave, expressed in milliVolts, measured in lead V5
Float
ECG 10s (CHRIS baseline)
x0ec110j
Q-Amplitude, V4
Voltage amplitude of the peak of Q wave, expressed in milliVolts, measured in lead V4
Float
ECG 10s (CHRIS baseline)
x0ec110i
Q-Amplitude, V3
Voltage amplitude of the peak of Q wave, expressed in milliVolts, measured in lead V3
Float
ECG 10s (CHRIS baseline)
x0ec110h
Q-Amplitude, V2
Voltage amplitude of the peak of Q wave, expressed in milliVolts, measured in lead V2
Float
ECG 10s (CHRIS baseline)
x0ec110g
Q-Amplitude, V1
Voltage amplitude of the peak of Q wave, expressed in milliVolts, measured in lead V1
Float
ECG 10s (CHRIS baseline)
x0ec110f
Q-Amplitude, aVF
Voltage amplitude of the peak of Q wave, expressed in milliVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec110e
Q-Amplitude, aVL
Voltage amplitude of the peak of Q wave, expressed in milliVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec110d
Q-Amplitude, aVR
Voltage amplitude of the peak of Q wave, expressed in milliVolts, measured in lead aVR
Float
ECG 10s (CHRIS baseline)
x0ec110a
Q-Amplitude, I
Voltage amplitude of the peak of Q wave, expressed in milliVolts, measured in lead I
Float
ECG 10s (CHRIS baseline)
x0ec106l
P-Amplitude negative, V6
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec106k
P-Amplitude negative, V5
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V5
Float
ECG 10s (CHRIS baseline)
x0ec106i
P-Amplitude negative, V3
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V3
Float
ECG 10s (CHRIS baseline)
x0ec106h
P-Amplitude negative, V2
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V2
Float
ECG 10s (CHRIS baseline)
x0ec106g
P-Amplitude negative, V1
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V1
Float
ECG 10s (CHRIS baseline)
x0ec106f
P-Amplitude negative, aVF
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec106e
P-Amplitude negative, aVL
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec106d
P-Amplitude negative, aVR
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead aVR
Float
ECG 10s (CHRIS baseline)
x0ec106c
P-Amplitude negative, III
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead III
Float
ECG 10s (CHRIS baseline)
x0ec106b
P-Amplitude negative, II
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead II
Float
ECG 10s (CHRIS baseline)
x0ec106a
P-Amplitude negative, I
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead I
Float
ECG 10s (CHRIS baseline)
x0ec105l
P-Amplitude positive, V6
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec105k
P-Amplitude positive, V5
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V5
Float
ECG 10s (CHRIS baseline)
x0ec105j
P-Amplitude positive, V4
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V4
Float
ECG 10s (CHRIS baseline)
x0ec105i
P-Amplitude positive, V3
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V3
Float
ECG 10s (CHRIS baseline)
x0ec105g
P-Amplitude positive, V1
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V1
Float
ECG 10s (CHRIS baseline)
x0ec105f
P-Amplitude positive, aVF
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec105e
P-Amplitude positive, aVL
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec105d
P-Amplitude positive, aVR
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead aVR
Float
ECG 10s (CHRIS baseline)
x0ec105c
P-Amplitude positive, III
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead III
Float
ECG 10s (CHRIS baseline)
x0ec105b
P-Amplitude positive, II
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead II
Float
Alcohol (CHRIS baseline)
x0al10
Daily alcohol intake (last 12 months)
Daily alcohol intake (continuous)
Float
Blood pressure (CHRIS baseline)
x0bp18c
Time of 3rd blood pressure measurement, CNAP
Time since measurement start, 3rd measurement
Float
Blood pressure (CHRIS baseline)
x0bp18b
Time of 2nd blood pressure measurement, CNAP
Time since measurement start, 2nd measurement
Float
Blood pressure (CHRIS baseline)
x0bp18a
Time of 1st blood pressure measurement, CNAP
Time since measurement start, 1st measurement
Float
Blood pressure (CHRIS baseline)
x0bp13
Pulse, CNAP
Pulse (mean over ECG 20 min)
Float
Heart rate variability (CHRIS baseline)
x0ec283t
MSE (t=20)
MSE (t=20): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 20
Float
Heart rate variability (CHRIS baseline)
x0ec283s
MSE (t=19)
MSE (t=19): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 19
Float
Heart rate variability (CHRIS baseline)
x0ec283r
MSE (t=18)
MSE (t=18): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 18
Float
Heart rate variability (CHRIS baseline)
x0ec283q
MSE (t=17)
MSE (t=17): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 17
Float
Heart rate variability (CHRIS baseline)
x0ec283p
MSE (t=16)
MSE (t=16): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 16
Float
Heart rate variability (CHRIS baseline)
x0ec283o
MSE (t=15)
MSE (t=15): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 15
Float
Heart rate variability (CHRIS baseline)
x0ec283n
MSE (t=14)
MSE (t=14): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 14
Float
Heart rate variability (CHRIS baseline)
x0ec283m
MSE (t=13)
MSE (t=13): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 13
Float
Heart rate variability (CHRIS baseline)
x0ec283l
MSE (t=12)
MSE (t=12): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 12
Float
Heart rate variability (CHRIS baseline)
x0ec283k
MSE (t=11)
MSE (t=11): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 11
Float
Heart rate variability (CHRIS baseline)
x0ec283i
MSE (t=9)
MSE (t=9): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 9
Float
Heart rate variability (CHRIS baseline)
x0ec283h
MSE (t=8)
MSE (t=8): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 8
Float
Heart rate variability (CHRIS baseline)
x0ec283g
MSE (t=7)
MSE (t=7): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 7
Float
Heart rate variability (CHRIS baseline)
x0ec283f
MSE (t=6)
MSE (t=6): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 6
Float
Heart rate variability (CHRIS baseline)
x0ec283e
MSE (t=5)
MSE (t=5): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 5
Float
Heart rate variability (CHRIS baseline)
x0ec283d
MSE (t=4)
MSE (t=4): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 4
Float
Heart rate variability (CHRIS baseline)
x0ec283c
MSE (t=3)
MSE (t=3): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 3
Float
Heart rate variability (CHRIS baseline)
x0ec283b
MSE (t=2)
MSE (t=2): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 2
Float
Heart rate variability (CHRIS baseline)
x0ec283a
MSE (t=1)
MSE (t=1): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 1
Float
Heart rate variability (CHRIS baseline)
x0ec282
RPA Shannon Entropy
RPA Shannon Entropy: it is the entropy of the probability distribution of the diagonal line lengths
Float
Heart rate variability (CHRIS baseline)
x0ec261
VLF power (%) (AR)
Relative power of VLF band, with PSD estimated using parametric autoregressive (AR) modeling method, expressed in ms^2
Float
Blood pressure (CHRIS baseline)
x0bp12
Diastolic blood pressure, CNAP
Diastolic blood pressure (mean of 3 measurements)
Float
Heart rate variability (CHRIS baseline)
x0ec279
RPA divergence
RPA divergence: Recurrence Plot Analysis is another approach for analyzing the complexity of the RR series, which consists in creating a symmetrical matrix of zeros and ones. The divergence (DIV) is defined as the inverse of Lmax
Float
Heart rate variability (CHRIS baseline)
x0ec278
RPA determinism
RPA determinism: Recurrence Plot Analysis is another approach for analyzing the complexity of the RR series, which consists in creating a symmetrical matrix of zeros and ones. The determinism (DET) is defined as the percentage of recurrence points which form diagonal lines
Float
Heart rate variability (CHRIS baseline)
x0ec277
RPA recurrence rate
RPA recurrence rate: Recurrence Plot Analysis is another approach for analyzing the complexity of the RR series, which consists in creating a symmetrical matrix of zeros and ones. The recurrence rate (REC) is defined as the ratio of ones and zeros in this RP matrix
Float
Heart rate variability (CHRIS baseline)
x0ec276
DFA alpha2
DFA alpha2: Detrended Fluctuation Analysis measures the correlation within the signal. Slope alpha2 characterizes long-term fluctuations or the RR series
Float
Heart rate variability (CHRIS baseline)
x0ec275
DFA alpha1
DFA alpha1: Detrended Fluctuation Analysis measures the correlation within the signal. Slope alpha1 characterizes short-term fluctuations or the RR series
Float
Heart rate variability (CHRIS baseline)
x0ec273
Sample Entropy
Sample Entropy: similar to ApEn, but it presents some differences in the calculation
Float
Heart rate variability (CHRIS baseline)
x0ec272
Approximate Entropy
Approximate Entropy: measures the complexity or irregularity of the signal. Large values of ApEn indicate high irregularity and smaller values of ApEn more regular signal
Float
Heart rate variability (CHRIS baseline)
x0ec270
Poincare SD2/SD1
Poincare SD2/SD1: ratio between SD2 and SD1
Float
Heart rate variability (CHRIS baseline)
x0ec269
Poincare SD2
Poincare SD2: in Poincare plot, SD2 represents the standard deviation along the line-of-identity
Float
Previous
1
31
32
33
34
35
43
Next